Legence (LGN) Stock Price

Legence Price

NYSE·CLOSED
32.35
​
Market closed

Revenue has compounded at 27.0% per year over the past 3 years to 2.45 B USD. Legence's net margin stands at -2.4%, up from -6.9% several years earlier. Analysts set a median price target of 99.00 USD, implying 206.0% above the current price. Of 22 analysts, 20 rate the stock a buy — an overall Buy consensus.

Legence stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Legence business model & stock analysis

Legence Corp generates revenue through its Engineering & Consulting and Installation & Maintenance segments. The Engineering & Consulting segment designs HVAC and MEP systems, develops energy reduction strategies, and provides project management for clients' installation and retrofit projects. The Installation & Maintenance segment fabricates and installs HVAC systems, process piping, and MEP systems in new and existing buildings, offering ongoing maintenance services. Legence Corp serves technically demanding sectors like technology, life sciences, healthcare, and education, targeting clients requiring specialized engineering and installation solutions for mission-critical systems. The company's primary customers are institutions and businesses in the technology, life sciences, healthcare, and education sectors. These clients purchase engineering design services, system installation, and maintenance contracts for their buildings' critical infrastructure. Legence Corp's focus on mission-critical systems in demanding environments ensures consistent demand for its specialized services, particularly in sectors where system reliability is paramount. Legence Corp's products include HVAC system designs, MEP system development, energy efficiency strategies, and maintenance contracts. The company's Engineering & Consulting segment delivers design and strategy services, while the Installation & Maintenance segment provides fabrication, installation, and maintenance services. These offerings cater to the needs of clients in the technology, life sciences, healthcare, and education sectors, where reliable building systems are essential for operations.

Frequently asked questions about Legence

Analysts currently set an average price target of 96.56 USD for the Legence stock (median: 99.00 USD), implying +198.5 % versus the latest price. The consensus is based on 22 analyst ratings.

22 analysts currently rate the Legence stock: 20 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Legence to generate revenue of 4.79 B USD and earnings per share of 2.41 USD.

Converted at the current exchange rate, the Legence share trades at 29.11 EUR (32.35 USD).

The expected revenue of Legence is 4.79 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Legence is 143.81 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Legence is currently 13.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Legence stock.

The price-to-sales ratio (P/S) of Legence is currently 0.40. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Legence stock.

The Eulerpool Quality Score for Legence is 4/10.

The ISIN of Legence is US52476L1098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Legence is LGN. The ticker symbol is used to trade Legence shares on the stock exchange.

Fair ValueTerminal
32.67 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Construction & Engineering
Number of shares
Employees
Revenue per Employee
349,816.14 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Sep 12, 2025
ISIN
US52476L1098
Cusip
52476L109
Market capitalization
3.49 B USDMid Cap
52-Week Range
PEG
-1.12
P/E ratio
P/Ee 2026
24.27
P/Ee 2027
12.19
P/Ee 2028
9.23
P/Ee 2029
7.52
P/Ee 2030
6.84
P/S
P/Se
0.40
EV/EBIT
46.46
P/B Ratio
8.90
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.12 %
Last updated Nov 12, 2026, 3:35 AM

Legence Peer Group

All fundamentals and in-depth analysis of Legence

Our stock analysis for Legence stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Legence. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.